187 related articles for article (PubMed ID: 31677525)
1. Generation of a WWTR1 mutation induced pluripotent stem cell line, MUSIi012-A-1, using CRISPR/Cas9.
Lorthongpanich C; Jiamvoraphong N; Supakun P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Laowtammathron C; Issaragrisil S
Stem Cell Res; 2019 Dec; 41():101634. PubMed ID: 31677525
[TBL] [Abstract][Full Text] [Related]
2. Generation of human induced pluripotent stem cell line carrying SCN5AC2204>T Brugada mutation (MUSli009-A-1) introduced by CRISPR/Cas9-mediated genome editing.
Angsutararux P; Luanpitpong S; Chingsuwanrote P; Supraditaporn K; Waeteekul S; Terbto P; Lorthongpanich C; Laowtammathron C; U-Pratya Y; Issaragrisil S
Stem Cell Res; 2019 Dec; 41():101618. PubMed ID: 31677524
[TBL] [Abstract][Full Text] [Related]
3. Generation of a PDX1-EGFP reporter human induced pluripotent stem cell line, KSCBi005-A-3, using the CRISPR/Cas9 system.
Lee Y; Choi HY; Kwon A; Park H; Park MH; Kim JW; Kim MJ; Kim YO; Kwak S; Koo SK
Stem Cell Res; 2019 Dec; 41():101632. PubMed ID: 31683099
[TBL] [Abstract][Full Text] [Related]
4. Generation of RUNX1c-eGFP induced pluripotent stem cell, MUSIi012-A-4, using CRISPR/Cas9.
Srisook P; Laowtammathron C; Lorthongpanich C; Klaihmon P; Terbto P; Waeteekul S; U-Pratya Y; Issaragrisil S
Stem Cell Res; 2023 Mar; 67():103035. PubMed ID: 36753833
[TBL] [Abstract][Full Text] [Related]
5. YAP-depleted iPSC MUSIi012-A-2 maintained all normal stem cell characteristics.
Lorthongpanich C; Laowtammathron C; Jiamvoraphong N; Srisook P; Chingsuwanrote P; Klaihmon P; Damkham N; Terbto P; Waeteekul S; U-Pratya Y; Issaragrisil S
Stem Cell Res; 2020 Mar; 43():101723. PubMed ID: 32018207
[TBL] [Abstract][Full Text] [Related]
6. Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing.
Feng H; Li Q; Margolis RL; Li PP
Stem Cell Res; 2021 May; 53():102346. PubMed ID: 34087983
[TBL] [Abstract][Full Text] [Related]
7. Generation of a TLR7 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9.
Han HJ; Seo HH; Han HW; Kim JH
Stem Cell Res; 2019 Oct; 40():101520. PubMed ID: 31445394
[TBL] [Abstract][Full Text] [Related]
8. Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9.
Yuan F; Guo D; Liu Y; Xu Y; Gao G; Wu Y; Yang F; Ke X; Lai K; Wei H; Li YX
Stem Cell Res; 2018 Jan; 26():67-71. PubMed ID: 29247816
[TBL] [Abstract][Full Text] [Related]
9. Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing.
Zhao H; He L; Huang H; Li S; Cheng N; Tang F; Han X; Lin Z; Huang R; Zhou P; Deng S; Huang J; Li Z
Stem Cell Res; 2020 Oct; 48():102003. PubMed ID: 32977294
[TBL] [Abstract][Full Text] [Related]
10. Creating a patient carried Men1 gene point mutation on wild type iPSCs locus mediated by CRISPR/Cas9 and ssODN.
Guo D; Liu H; Gao G; Liu Y; Zhuang Y; Yang F; Wang K; Zhou T; Qin D; Hong L; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jan; 18():67-69. PubMed ID: 28395809
[TBL] [Abstract][Full Text] [Related]
11. Generation of a heterozygous COL2A1 (p.R989C) spondyloepiphyseal dysplasia congenita mutation iPSC line, MCRIi001-B, using CRISPR/Cas9 gene editing.
Lilianty J; Nur Patria Y; Stanley EG; Elefanty AG; Bateman JF; Lamandé SR
Stem Cell Res; 2020 May; 45():101843. PubMed ID: 32446218
[TBL] [Abstract][Full Text] [Related]
12. Generation of a TLR2 homozygous knockout human embryonic stem cell line WAe001-A-64 using CRISPR/Cas9 editing.
Getachew A; Yang Z; Huang X; Wu F; Liu YY; Yan C; Yang F; Li Y
Stem Cell Res; 2021 Jul; 54():102401. PubMed ID: 34058685
[TBL] [Abstract][Full Text] [Related]
13. Generation of a homozygous ARHGAP11B knockout hiPSC line by CRISPR/Cas9 system.
Liu Y; Jin Y; Chen T; Wu Y; Peng X; Li W; Wei S; Chen M; Zou Q; Guo S; Xu J; Tang C; Zhou X
Stem Cell Res; 2022 May; 61():102764. PubMed ID: 35358830
[TBL] [Abstract][Full Text] [Related]
14. Generation of two compound heterozygous HGSNAT-mutated lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo C syndrome.
Benetó N; Cozar M; García-Morant M; Creus-Bachiller E; Vilageliu L; Grinberg D; Canals I
Stem Cell Res; 2019 Dec; 41():101616. PubMed ID: 31731183
[No Abstract] [Full Text] [Related]
15. Cell type-specific YAP1-WWTR1/TAZ transcriptional responses after autophagy perturbations are determined by levels of α-catenins (CTNNA1 and CTNNA3).
Pavel M; Park SJ; Tanasa R; Rubinsztein DC
Autophagy; 2021 Jul; 17(7):1788-1790. PubMed ID: 34036899
[TBL] [Abstract][Full Text] [Related]
16. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
[TBL] [Abstract][Full Text] [Related]
17. Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing.
Bogomiakova ME; Sekretova EK; Eremeev AV; Shuvalova LD; Bobrovsky PA; Zerkalenkova EA; Lebedeva OS; Lagarkova MA
Stem Cell Res; 2021 Aug; 55():102451. PubMed ID: 34237591
[TBL] [Abstract][Full Text] [Related]
18. Recurrent WWTR1 S89W mutations and Hippo pathway deregulation in clear cell carcinomas of the cervix.
Kim SH; Basili T; Dopeso H; Da Cruz Paula A; Bi R; Issa Bhaloo S; Pareja F; Li Q; da Silva EM; Zhu Y; Hoang T; Selenica P; Murali R; Chan E; Wu M; Derakhshan F; Maroldi A; Hanlon E; Ferreira CG; Lapa E Silva JR; Abu-Rustum NR; Zamarin D; Chandarlapaty S; Matrai C; Yoon JY; Reis-Filho JS; Park KJ; Weigelt B
J Pathol; 2022 Aug; 257(5):635-649. PubMed ID: 35411948
[TBL] [Abstract][Full Text] [Related]
19. Generation of a human induced pluripotent stem cell line with Cas9 driven by Tet-on operator via AAVS1 safe harbor gene-editing.
Ding Y; Wang L; Ji W; Chen Z; Wang D; Chen C; Tong H; Han Z; Niu C; Chu M; Huang J; Guo X
Stem Cell Res; 2020 Dec; 49():102064. PubMed ID: 33207306
[TBL] [Abstract][Full Text] [Related]
20. Generation of NERCe003-A-3, a p53 compound heterozygous mutation human embryonic stem cell line, by CRISPR/Cas9 editing.
Li Y; Huang C; Zha L; Kong M; Yang Q; Zhu Y; Peng Y; Ouyang Q; Lu G; Lin G; Zhou D
Stem Cell Res; 2019 Jan; 34():101371. PubMed ID: 30658254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
